AMD3465, a monomacrocyclic CXCR4 antagonist and potent HIV entry inhibitor

Sigrid Hatse; Katrien Princen; De Clercq Erik; Mette M. Rosenkilde; Thue W. Schwartz; Pedro E. Hernandez-Abad; Renato T. Skerlj; Gary Bridger; Dominique Schols

doi:10.1016/j.bcp.2005.05.035

Related publications

Article1998

AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor

G A Donzella, Dominique Schols, Steven Lin, José A. Esté, Kirsten Nagashima, Paul J. Maddon, Graham P. Allaway, Thomas P. Sakmar, Geoffrey Henson, De Clercq Erik, John P. Moore

Article2001

CXCR4 antagonists as HIV entry inhibitors

Katrien Princen, Sigrid Hatse, Kurt Vermeire, Gary Bridger, Renato T. Skerlj, De Clercq Erik, Dominique Schols

Article2001

AMD3100, a potent and specific CXCR4 antagonist, inhibits autoimmune joint inflammation in mice

Patrick Matthys, Sigrid Hatse, Kurt Vermeire, Anja Wuyts, Gary Bridger, De Clercq Erik, Alfons Billiau, Dominique Schols

Article2004

In vitro anti-HIV activity profile of AMD887, a novel CCR5 antagonist, in combination with the CXCR4 inhibitor AMD070

Dominique Schols, Kurt Vermeire, Sigrid Hatse, Katrien Princen, De Clercq Erik, Gary Calandra, Simon P. Fricker, Kim L. Nelson, J Labrecque, David Bogucki, Ya-Shi Zhou, Renato T. Skerlj, Gary Bridger

Article2003

Mutations at the CXCR4 interaction sites for AMD3100 influence anti‐CXCR4 antibody binding and HIV‐1 entry

Sigrid Hatse, Katrien Princen, Kurt Vermeire, Lars‐Ole Gerlach, Mette M. Rosenkilde, Thue W. Schwartz, Gary Bridger, De Clercq Erik, Dominique Schols